Evidence map›Paper›PMID 41969449›Full record

ArticleTranslational cancer research2026

Short-term response to alectinib and rapid progression in a lung squamous cell carcinoma patient harboring an

Shengshu Li, Xiaosong Du, Xinxin Zhang, Haixia Ma, Yanli Yang, Yuan Li, Qin Wei, Yan Chen, Hongwei Li, Peng Bu and 3 more

Abstract readCase Reports
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shengshu Li *Department of Respiratory Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Xiaosong Du *Department of Radiology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Xinxin Zhang *College of Pulmonary and Critical Care Medicine, the Eighth Medical Centre, Chinese PLA General Hospital, Beijing, China.
Haixia MaDepartment of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Yanli YangDepartment of Respiratory Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Yuan LiDepartment of Respiratory Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Qin WeiXiamen SpaceGen Co., Ltd., Xiamen, China.
Yan ChenXiamen SpaceGen Co., Ltd., Xiamen, China.
Hongwei LiDepartment of Radiation Oncology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Peng BuDepartment of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Dujuan LiuDepartment of Medicine, Suzhou SpaceSeq MedLab Co., Ltd., Suzhou, China.
Songyan HanDepartment of Respiratory Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
Deyi ChenDepartment of Medicine, Suzhou SpaceSeq MedLab Co., Ltd., Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Anaplastic lymphoma kinase ( Case Description: A 56-year-old female patient with a history of cervical cancer, who had undergone cervicectomy 16 years earlier, presented complaining of shortness of breath for one week. Her chest computed tomography (CT) showed a large right pleural effusion. Fine-needle aspiration of the right hilar lymph node revealed metastatic squamous carcinoma, and the patient was diagnosed with stage IVA LUSCC. Polymerase chain reaction test showed positive for Conclusions: We reported a rare case of

Indexed as

alectinibcase reportco-amplificationEML4-ALKLung squamous cell carcinoma (LUSCC)

Identifiers

PMID41969449
PMCPMC13067192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.